Request Sample
Request Methodology
Description
Anatomic Pathology Market size was valued at USD 37.9 billion in 2021 and is expected to reach a value of USD 58.9 billion by 2028 witnessing a CAGR rate of 6.5% during the forecast period 2022-2028. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the Anatomic Pathology Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the Anatomic Pathology Market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product opportunities). The anatomic pathology is a branch of science that involves in molecular, biochemical and microscopic analysis of tissues and organs in order to find the effectiveness of diseases. The main objective of anatomic pathology is the identification of abnormalities to manage treatment and diagnosis. This can be helpful diagnosis of different types of cancers. The global anatomic pathology market is surging owing to frequent acquisitions and collaborations by the market players. For instance, In November 2018, Quest Diagnostics, Inc. agreed to acquire the assets of the clinical laboratory services business of Boyce and Bynum Pathology Laboratories or BBPL including anatomic pathology services. Moreover, In December 2018, Sonic Healthcare acquired Aurora Diagnostics to expand its anatomic pathology services in U.S.
